Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Breast Cancer

  Free Subscription


Articles published in Am J Surg Pathol

Retrieve available abstracts of 21 articles:
HTML format



Single Articles


    September 2024
  1. LI X, Nguyen TTA, Zhang J, Nayak A, et al
    Validation Study of the Newly Proposed Refined Diagnostic Criteria for Malignant Phyllodes Tumor With 136 Borderline and Malignant Phyllodes Tumor Cases.
    Am J Surg Pathol. 2024;48:1146-1153.
    PubMed     Abstract available


    June 2024
  2. IVANOVA VS, Menter T, Zaino J, Mertz KD, et al
    The Genetic Landscape of Primary Breast Marginal Zone Lymphoma Identifies a Mutational-driven Disease With Similarities to Ocular Adnexal Lymphoma.
    Am J Surg Pathol. 2024 Jun 12. doi: 10.1097/PAS.0000000000002257.
    PubMed     Abstract available


  3. MARQUES-PIUBELLI ML, Lyapichev KA, Fnu A, Adrada B, et al
    The Spectrum of Non-neoplastic Changes Associated With Breast Implants: Histopathology, Imaging, and Clinical Significance.
    Am J Surg Pathol. 2024;48:e43-e64.
    PubMed     Abstract available


    May 2024
  4. RETAMERO JA, Gulturk E, Bozkurt A, Liu S, et al
    Artificial Intelligence Helps Pathologists Increase Diagnostic Accuracy and Efficiency in the Detection of Breast Cancer Lymph Node Metastases.
    Am J Surg Pathol. 2024 May 29. doi: 10.1097/PAS.0000000000002248.
    PubMed     Abstract available


    April 2024
  5. LENNARTZ M, Lohr N, Hoflmayer D, Dwertmann Rico S, et al
    TRPS1 is a Highly Sensitive Marker for Breast Cancer: A Tissue Microarray Study Evaluating More Than 19,000 Tumors From 152 Different Tumor Entities.
    Am J Surg Pathol. 2024 Apr 22. doi: 10.1097/PAS.0000000000002213.
    PubMed     Abstract available


    January 2024
  6. WU L, Chen M, Lin Y, Zeng B, et al
    Prognostic Value of Immunohistochemistry-based Subtyping Before and After Neoadjuvant Chemotherapy in Patients with Triple-negative Breast Cancer.
    Am J Surg Pathol. 2024;48:27-35.
    PubMed     Abstract available


    October 2023
  7. KERVARREC T, Imbeaud S, Veyer D, Pere H, et al
    Digital Papillary Adenocarcinoma in Nonacral Skin: Clinicopathologic and Genetic Characterization of 5 Cases.
    Am J Surg Pathol. 2023;47:1077-1084.
    PubMed     Abstract available


    September 2023
  8. WANG Y, Hacking SM, Li Z, Graff SL, et al
    Triple-negative Breast Carcinoma With Apocrine and Histiocytoid Features: A Clinicopathologic and Molecular Study of 18 Cases.
    Am J Surg Pathol. 2023;47:1011-1018.
    PubMed     Abstract available


    August 2023
  9. WEIGELT MA, Sciallis AP, McIntire PJ, Ko JS, et al
    Nipple Adenoma: Clinicopathologic Characterization of 50 Cases.
    Am J Surg Pathol. 2023;47:926-932.
    PubMed     Abstract available


    July 2023
  10. PUN C, Turashvili G, Mulligan AM, Slodkowska E, et al
    Mammary Spindle Cell Proliferations on Core Needle Biopsy: Is Excision Always Necessary?
    Am J Surg Pathol. 2023;47:826-834.
    PubMed     Abstract available


    March 2023
  11. JOEHLIN-PRICE AS, Komforti MK, Ladwig NR, Devine P, et al
    HER2 IHC Expression and Gene Amplification in p53-aberrant High-grade Endometrial Endometrioid Carcinoma Suggests That This Population May Benefit From HER2 Testing and Targeted Therapy.
    Am J Surg Pathol. 2023 Mar 20. doi: 10.1097/PAS.0000000000002030.
    PubMed     Abstract available


  12. HODA SA, Hoda RS
    "Time Shall Unfold...": The Clinical Value of Grading Mammary Angiosarcoma.
    Am J Surg Pathol. 2023;47:279-280.
    PubMed    


  13. BARANOV E, Alston ELJ, Lester SC, Fletcher CDM, et al
    Angiomyxoma of the Breast: A Clinicopathologic Analysis of 40 Cases.
    Am J Surg Pathol. 2023;47:296-306.
    PubMed     Abstract available


    February 2023
  14. CALLE C, Zhong E, Hanna MG, Ventura K, et al
    Changes in the Diagnoses of Breast Core Needle Biopsies on Second Review at a Tertiary Care Center: Implications for Surgical Management.
    Am J Surg Pathol. 2023;47:172-182.
    PubMed     Abstract available


    January 2023
  15. SHAKER N, Shafi S, Parkinson B, Chen W, et al
    Wnt Family Member 9b (Wnt9b) Is a Sensitive and Specific Marker for Triple-negative Breast Carcinoma Including Metaplastic Carcinoma.
    Am J Surg Pathol. 2023;47:47-54.
    PubMed     Abstract available


    November 2022
  16. PEREZ-MIES B, Caniego-Casas T, Carretero-Barrio I, Biscuola M, et al
    The Clonal Relationship Between the Ductal and Lobular Components of Mixed Ductal-Lobular Carcinomas Suggested a Ductal Origin in Most Tumors.
    Am J Surg Pathol. 2022;46:1545-1553.
    PubMed     Abstract available


    July 2022
  17. BUTCHER MR, White MJ, Rooper LM, Argani P, et al
    MYB RNA In Situ Hybridization Is a Useful Diagnostic Tool to Distinguish Breast Adenoid Cystic Carcinoma From Other Triple-negative Breast Carcinomas.
    Am J Surg Pathol. 2022;46:878-888.
    PubMed     Abstract available


    May 2022
  18. ONKEN AM, Collins LC, Schnitt SJ
    Mucin Neovascularization as a Diagnostic Aid to Distinguish Mucinous Carcinomas From Mucocele-like Lesions in Breast Core Needle Biopsies.
    Am J Surg Pathol. 2022;46:637-642.
    PubMed     Abstract available


    March 2022
  19. PARKINSON B, Chen W, Shen T, Parwani AV, et al
    TRPS1 Expression in Breast Carcinomas: Focusing on Metaplastic Breast Carcinomas.
    Am J Surg Pathol. 2022;46:415-423.
    PubMed     Abstract available


  20. YASUI H, Kawata T, Muramatsu K, Kakuda Y, et al
    Expression of N-Terminal-Deficient E-Cadherin Protein in Invasive Lobular Carcinoma of the Breast.
    Am J Surg Pathol. 2022;46:383-391.
    PubMed     Abstract available


    December 2021
  21. CHUANG AY, Watkins JC, Young RH, Lerwill MF, et al
    Lobular Carcinoma of the Breast Metastatic to the Ovary: A Clinicopathologic Study of 38 Cases.
    Am J Surg Pathol. 2021 Dec 21. pii: 00000478-900000000-97082.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.